MS affects women two to three times more commonly than men. Most patients start with a period of unpredictable relapses and remissions, which in the majority is followed by an accumulation of neurologic dysfunction and a chronic progressive course. The life expectancy has been shown to be only 6 to 7 years less than that for control population without but the emotional and economic cost to society as a result of the disability is enormous.